Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...
Boston Scientific has agreed to acquire Penumbra in a cash-and-stock deal worth $14.5 billion. The addition of Penumbra, ...
Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...
Wild axolotls are facing extinction. That’s the bad news. But take heart: Cutie-pie axolotls bred in captivity may be able to ...
The consequences could be severe. With paylines at most NIH Institutes well below 10 percent, every award not based on merit ...
Lived experiences shape how science is conducted. This matters because who gets to speak for science steers which problems ...
A new report finds that a majority of Americans think the U.S. should be a world leader in science, but Democrats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback